The purpose of this study is to elucidate the factors which are associated with the diagnosis and predict prognosis and therapeutic targets by collecting specimens of tissue sample, peripheral blood, and bone marrow aspirates at the time of diagnosis or relapse/refractory in patients with malignant hematologic disorders except acute leukemia. This study is eligible for patients who are diagnosed with malignant hematologic disorders except acute leukemia or who will have diagnostic procedure with suspicion of having hematologic malignancy. Prospective cohort is for patients who are not in treatment for hematologic malignancy. Retrospective cohort is for patients who are diagnosed and in treatment.

Inclusion Criteria:

• The patients with malignant hematologic disorders except acute leukemia who are diagnosed pathologically according to the revised 2008 WHO classification of tumours of haematopoietic and lymphoid tissue or who will have diagnostic procedure with suspicion of having hematologic malignancy.
• Any gender and age ≥ 19 years
• Written informed consent
• Diagnosed after 2005-01-01 in retrospective cohort group.

Exclusion Criteria:

• Patients who cannot understand or disagree the informed consent
• Patients who diagnosed with acute leukemia

Patients with newly diagnosed or relapsed malignant hematologic disorders except acute leukemia